Cover Image
Market Research Report

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019

Published by GlobalData Product code 363398
Published Content info 155 Pages
Delivery time: 1-2 business days
Price
Back to Top
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019
Published: December 1, 2019 Content info: 155 Pages
Description

GlobalData's Medical Devices sector report, "Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2019" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Point-of-Care (POC) Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0825EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 7
  • 1.2 List of Figures 11

2 Introduction 12

  • 2.1 Point-of-Care (POC) Analyzers Overview 12

3 Products under Development 13

  • 3.1 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 13
  • 3.2 Point-of-Care (POC) Analyzers - Pipeline Products by Territory 14
  • 3.3 Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 15
  • 3.4 Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 16
  • 3.5 Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 17

4 Point-of-Care (POC) Analyzers - Pipeline Products under Development by Companies 18

  • 4.1 Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 18
  • 4.2 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 21

5 Point-of-Care (POC) Analyzers Companies and Product Overview 24

  • 5.1 Access Bio Inc Company Overview 24
    • 5.1.1 Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.2 Acrongenomics Inc (Inactive) Company Overview 25
    • 5.2.1 Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.3 AgPlus Diagnostics LTD Company Overview 26
    • 5.3.1 AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.4 Akers Biosciences Inc Company Overview 27
    • 5.4.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.5 Akonni Biosystems Inc Company Overview 29
    • 5.5.1 Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.6 Alere Inc Company Overview 30
    • 5.6.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.7 Analytical Diagnostic Solutions Inc Company Overview 31
    • 5.7.1 Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.8 ApoCell Inc Company Overview 33
    • 5.8.1 ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.9 Aptatek BioSciences Inc Company Overview 34
    • 5.9.1 Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.10 Atonomics A/S Company Overview 35
    • 5.10.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.11 BBB Technologies Inc Company Overview 36
    • 5.11.1 BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.12 Binghampton University Company Overview 37
    • 5.12.1 Binghampton University Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.13 Bio-AMD Inc Company Overview 38
    • 5.13.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.14 BioMedomics Inc Company Overview 39
    • 5.14.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.15 Biopico Systems Inc Company Overview 40
    • 5.15.1 Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.16 Biosensia Ltd Company Overview 41
    • 5.16.1 Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.17 Boston University Company Overview 42
    • 5.17.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.18 BreviTest Technologies LLC Company Overview 43
    • 5.18.1 BreviTest Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.19 Brigham and Women's Hospital Company Overview 44
    • 5.19.1 Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.20 Calmark Sweden AB Company Overview 45
    • 5.20.1 Calmark Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.21 Canon USA Inc Company Overview 47
    • 5.21.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.22 CardioGenics Inc Company Overview 48
    • 5.22.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.23 Center for Innovation in Point-of-Care Technologies for HIV/AIDS Company Overview 49
    • 5.23.1 Center for Innovation in Point-of-Care Technologies for HIV/AIDS Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.24 Cepheid Company Overview 51
    • 5.24.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.25 ChipCare Corp Company Overview 54
    • 5.25.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.26 City, University of London Company Overview 55
    • 5.26.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.27 Co-Diagnostics Inc Company Overview 56
    • 5.27.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.28 Cornell University Company Overview 57
    • 5.28.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.29 Cutting Edge Medical Devices Limited Company Overview 58
    • 5.29.1 Cutting Edge Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.30 Diagnostics For All Inc Company Overview 59
    • 5.30.1 Diagnostics For All Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.31 Duke University Company Overview 60
    • 5.31.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.32 EKF Diagnostics Holdings Plc Company Overview 61
    • 5.32.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.33 Endeavor Sciences Inc Company Overview 62
    • 5.33.1 Endeavor Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.34 ExcitePCR Corp Company Overview 63
    • 5.34.1 ExcitePCR Corp Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.35 Exosome Diagnostics Inc Company Overview 64
    • 5.35.1 Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.36 Fawkes Biotechnology LLC Company Overview 65
    • 5.36.1 Fawkes Biotechnology LLC Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.37 First Light Diagnostics Inc Company Overview 66
    • 5.37.1 First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.38 Florida International University Company Overview 67
    • 5.38.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.39 Future Diagnostics Solutions BV Company Overview 68
    • 5.39.1 Future Diagnostics Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.40 Giner Inc Company Overview 69
    • 5.40.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.41 GlucoSentient Inc Company Overview 70
    • 5.41.1 GlucoSentient Inc Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.42 Indian Institute of Science Company Overview 71
    • 5.42.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.43 Indian Institute of Technology Chennai Company Overview 72
    • 5.43.1 Indian Institute of Technology Chennai Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.44 Lucendi Inc Company Overview 73
    • 5.44.1 Lucendi Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.45 Masaryk University Company Overview 74
    • 5.45.1 Masaryk University Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.46 Maxygen-mobile DNA tests Company Overview 75
    • 5.46.1 Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.47 mBio Diagnostics Inc Company Overview 76
    • 5.47.1 mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.48 McKesson Corp Company Overview 78
    • 5.48.1 McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.49 Meridian Bioscience Inc Company Overview 79
    • 5.49.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.50 MML Ltd Company Overview 80
    • 5.50.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.51 Molecular Warehouse Ltd Company Overview 81
    • 5.51.1 Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
  • 5.52 Nalia Systems Ltd Company Overview 82
    • 5.52.1 Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 82
  • 5.53 Newcastle University Company Overview 83
    • 5.53.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 83
  • 5.54 Nikkiso Co Ltd Company Overview 85
    • 5.54.1 Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.55 Ohmx Corp Company Overview 86
    • 5.55.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 86
  • 5.56 OncoGenesis Company Overview 87
    • 5.56.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 87
  • 5.57 Ontera Inc Company Overview 88
    • 5.57.1 Ontera Inc Pipeline Products & Ongoing Clinical Trials Overview 88
  • 5.58 Pacific Nanoscience, Inc. Company Overview 89
    • 5.58.1 Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 89
  • 5.59 POC Medical Systems Inc Company Overview 90
    • 5.59.1 POC Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 90
  • 5.60 ProciseDx LLC Company Overview 91
    • 5.60.1 ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview 91
  • 5.61 Quanterix Corp Company Overview 92
    • 5.61.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 92
  • 5.62 Qvella Corp Company Overview 93
    • 5.62.1 Qvella Corp Pipeline Products & Ongoing Clinical Trials Overview 93
  • 5.63 Radisens Diagnostics Ltd Company Overview 94
    • 5.63.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
  • 5.64 Raman Diagnostics Ltd (Inactive) Company Overview 95
    • 5.64.1 Raman Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 95
  • 5.65 RMIT University Company Overview 96
    • 5.65.1 RMIT University Pipeline Products & Ongoing Clinical Trials Overview 96
  • 5.66 SeLux Diagnostics Inc Company Overview 97
    • 5.66.1 SeLux Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 97
  • 5.67 SenGenix Inc Company Overview 99
    • 5.67.1 SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 99
  • 5.68 StemTek Therapeutics SL Company Overview 100
    • 5.68.1 StemTek Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 100
  • 5.69 Thermal Gradient Inc Company Overview 101
    • 5.69.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 101
  • 5.70 Trinity Biotech Plc Company Overview 103
    • 5.70.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 103
  • 5.71 University of Calgary Company Overview 105
    • 5.71.1 University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 105
  • 5.72 University of California Berkeley Company Overview 106
    • 5.72.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 106
  • 5.73 University of Glasgow Company Overview 109
    • 5.73.1 University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 109
  • 5.74 University of Illinois at Chicago Company Overview 110
    • 5.74.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 110
  • 5.75 Wellstat Diagnostics LLC Company Overview 111
    • 5.75.1 Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 111

6 Point-of-Care (POC) Analyzers- Recent Developments 112

  • 6.1 Oct 30, 2019: First Light Diagnostics joins global initiative to combat antibiotic resistance 112
  • 6.2 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results 112
  • 6.3 Oct 23, 2019: bioMerieux - Third-Quarter 2019 Business Review 114
  • 6.4 Oct 22, 2019: bioMerieux - Third quarter 2019 business review 115
  • 6.5 Oct 18, 2019: Calmark extends the time plan for CE-mark of the biomarkers LDH and Glucose - market launch as according to plan 117
  • 6.6 Oct 18, 2019: McKesson's Board of Directors appoints Maria Martinez as new independent Director 117
  • 6.7 Oct 16, 2019: BioDirection announces move of corporate headquarters to Southborough, Massachusetts 118
  • 6.8 Oct 08, 2019: Results for Calmark's initial biomarker, bilirubin, are within the expected range - project enters verification and validation phase to obtain CE mark 119
  • 6.9 Oct 02, 2019: Selux Diagnostics beats key contract milestone, receives $11.4m in additional funding 119
  • 6.10 Sep 25, 2019: Dr. Joanne Spadoro Joins First Light Diagnostics 120

7 Appendix 152

  • 7.1 Methodology 152
  • 7.2 About GlobalData 155
  • 7.3 Contact Us 155
  • 7.4 Disclaimer 155

List of Tables

  • Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 14
  • Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 15
  • Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 16
  • Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 17
  • Table 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 18
  • Table 6: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 19
  • Table 7: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 22
  • Table 8: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 9: All-in-One Sensor - Product Status 25
  • Table 10: All-in-One Sensor - Product Description 25
  • Table 11: Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 12: BioLED Device - Diabetes Management - Product Status 27
  • Table 13: BioLED Device - Diabetes Management - Product Description 27
  • Table 14: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 15: AgPlus Diagnostic System - Product Status 28
  • Table 16: AgPlus Diagnostic System - Product Description 28
  • Table 17: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 18: minDNAnalyzer - Product Status 29
  • Table 19: minDNAnalyzer - Product Description 30
  • Table 20: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 21: TruDx 2000 Platform - Product Status 31
  • Table 22: TruDx 2000 Platform - Product Description 31
  • Table 23: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 24: Clondiag HIV Molecular Device - Product Status 32
  • Table 25: Clondiag HIV Molecular Device - Product Description 32
  • Table 26: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 27: BiliNow - Product Status 33
  • Table 28: BiliNow - Product Description 33
  • Table 29: PKU Now - Product Status 34
  • Table 30: PKU Now - Product Description 34
  • Table 31: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 32: ApoStream System - Product Status 35
  • Table 33: ApoStream System - Product Description 35
  • Table 34: Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 35: Point Of Care Diagnostic Device - Phenylketonuria - Product Status 36
  • Table 36: Point Of Care Diagnostic Device - Phenylketonuria - Product Description 36
  • Table 37: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 38: Atolyzer PoC - Product Status 37
  • Table 39: Atolyzer PoC - Product Description 37
  • Table 40: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 41: markB - Product Status 38
  • Table 42: markB - Product Description 38
  • Table 43: Binghampton University Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 44: U-PAC - Product Status 40
  • Table 45: U-PAC - Product Description 40
  • Table 46: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 47: Magnetic Immunoassay Detection System - Product Status 42
  • Table 48: Magnetic Immunoassay Detection System - Product Description 42
  • Table 49: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 50: TR-LFIA Diagnostic Analyzer - Product Status 44
  • Table 51: TR-LFIA Diagnostic Analyzer - Product Description 44
  • Table 52: Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 53: MONITOR System - Product Status 45
  • Table 54: MONITOR System - Product Description 45
  • Table 55: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 56: RapiPlex System - Product Status 46
  • Table 57: RapiPlex System - Product Description 46
  • Table 58: Boston University Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 59: Point-Of-Care Device - Allergen-Specific IgE - Product Status 47
  • Table 60: Point-Of-Care Device - Allergen-Specific IgE - Product Description 47

List of Figures

  • Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 13
  • Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 14
  • Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 15
  • Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 16
  • Figure 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 17
Back to Top